Home/ Supplements/ Niacin/ SuperHuman Burn Smurf Juice Blue Gummy B...

SuperHuman Burn Smurf Juice Blue Gummy Bear

product on market Powder Alpha Lion Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Niacin and Vitamin B12 support cellular energy metabolism, while the pump and energy matrices typically target blood flow and alertness. There is strong evidence for the role of B vitamins in energy production, though evidence for the specific proprietary matrices is limited. The product maintains a high safety profile.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for SuperHuman Burn Smurf Juice Blue Gummy Bear
Open Full PDF View on NIH DSLD →
Details

Label Data

8.5 Gram(s)
Serving Size
25
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

25 mg NE (156% DV)
1.8× RDA — within safe limits 196 studies (A:5, B:63)
500 mcg (20834% DV)
208.3× RDA — above typical dose 139 studies (A:1, B:44)
Sodium
50 mg (2% DV)
Superhuman Pump & Performance Matrix
Superhuman Energy Matrix
Superhuman Fat Burn Matrix
Superhuman Focus Matrix
Superhuman Absorption Matrix

Other Ingredients

Malic Acid Natural & Artificial Flavors Silicon Dioxide Calcium Silicate Sucralose Acesulfame Potassium FD&C Yellow #5 FD&C Blue #1
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Formulation Notes

High octane pre-workout + fat burner

Blue Gummy Bear natural and artificial flavors

Additional Information

Servings Per Container: 50 (1 Scoop)/25 (2 Scoops)

Metadata

Product Details

DSLD Entry Date2022-06-16
Product TypeOther Combinations
FormPowder
DSLD ID268668
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.